For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Peterborough, Ontario K9J 1Z2

0 studies enrolling now · 5 studies all time

What they study most

Alzheimer's Disease, Diabetes Mellitus, Type 1, Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous

Studies at this site

• A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2) — Completed
• Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo — Stopped early
• A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis — Completed
• Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes — Completed
• Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo — Completed